|
Volumn 12, Issue 7, 1998, Pages 824-825
|
Persistence of HIV-1 variants harbouring the zidovudine resistance mutation at pol codon 215 in patients who respond to triple combination therapy [6]
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIRETROVIRUS AGENT;
DIDANOSINE;
INDINAVIR;
LAMIVUDINE;
POL PROTEIN;
STAVUDINE;
ZIDOVUDINE;
CLINICAL ARTICLE;
CODON;
FEMALE;
GENE MUTATION;
GENETIC VARIABILITY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LETTER;
MALE;
NONHUMAN;
PRIORITY JOURNAL;
STRUCTURAL GENE;
ADULT;
ANTI-HIV AGENTS;
CODON;
DRUG RESISTANCE, MICROBIAL;
DRUG THERAPY, COMBINATION;
FEMALE;
GENES, POL;
HIV INFECTIONS;
HIV PROTEASE INHIBITORS;
HIV-1;
HUMANS;
INDINAVIR;
LAMIVUDINE;
MALE;
MUTATION;
PROSPECTIVE STUDIES;
REVERSE TRANSCRIPTASE INHIBITORS;
STAVUDINE;
TREATMENT OUTCOME;
VIRUS LATENCY;
ZIDOVUDINE;
|
EID: 0032492997
PISSN: 02699370
EISSN: None
Source Type: Journal
DOI: None Document Type: Letter |
Times cited : (9)
|
References (11)
|